Doctors should be "warning their patients about these products, not providing them," he said
B12 supplementation in elderly patients with confirmed deficiency typically takes two main forms in the UK: Oral tablets (cyanocobalamin) Intramuscular injections (hydroxocobalamin, the standard form in the UK) NICE Clinical Knowledge Summary guidance recommends investigating B12 deficiency in older adults presenting with unexplained anaemia, neuropathy, cognitive impairment, or glossitis
Neuroton Injection: A similar alternative to Neurobion, Neuroton injection also contains B-complex vitamins for nerve support and metabolic enhancement
Theoretical Risks with Chronic Use Some concerns raised by clinicians and researchers include: Unregulated angiogenesis: Overstimulation of blood vessel growth could hypothetically support tumor progression in cancer-prone individuals Unknown hormonal crosstalk: While BPC-157 is non-hormonal, it interacts with systems (e.g., nitric oxide, dopamine) that may influence downstream signaling Immune tolerance or desensitization: Chronic exposure to any peptide could alter immune recognition or receptor sensitivity over time These concerns are theoretical , but they highlight why BPC-157 should not be used indefinitely or in uncontrolled cycles
Primary Cellular Pathways BPC-157: FAK/Paxillin Signaling Cell Migration & Adhesion Research has demonstrated that BPC-157 significantly increases phosphorylation of focal adhesion kinase (FAK) and paxillin proteins in fibroblast cells[1]
Your treatment will start with a 'loading dose' phasea series of frequent injections to rapidly build your B12 levels back up and halt any further nerve damage